2,200 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Board of the Pension Protection Fund

Board of the Pension Protection Fund acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 2,200 shares of the biotechnology company's stock, valued at approximately $1,308,000. Axon Enterprise accounts for approximately 1.5% of Board of the Pension Protection Fund's portfolio, making the stock its 2nd biggest position.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board raised its stake in Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock valued at $1,240,000 after purchasing an additional 500 shares during the period. CIBC Asset Management Inc raised its position in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock valued at $4,227,000 after buying an additional 895 shares during the last quarter. Foundations Investment Advisors LLC purchased a new position in shares of Axon Enterprise in the third quarter worth $221,000. Sequoia Financial Advisors LLC boosted its position in shares of Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company's stock worth $690,000 after acquiring an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC bought a new position in shares of Axon Enterprise during the third quarter worth $814,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Trading Up 0.0 %

NASDAQ AXON traded up $0.20 during trading on Wednesday, hitting $580.00. The stock had a trading volume of 701,948 shares, compared to its average volume of 689,837. Axon Enterprise, Inc. has a one year low of $246.99 and a one year high of $698.67. The stock has a 50 day simple moving average of $612.80 and a 200 day simple moving average of $454.94. The stock has a market capitalization of $44.23 billion, a price-to-earnings ratio of 149.87, a P/E/G ratio of 14.19 and a beta of 1.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Analyst Ratings Changes

Several analysts have commented on AXON shares. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a research note on Wednesday, October 23rd. JMP Securities increased their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research note on Thursday, October 31st. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research report on Friday, November 8th. Finally, Robert W. Baird boosted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $504.92.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the company's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.